drugset
drugset / Trial / NCT01161615

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

NCT01161615 ↗

Phase 3 Completed 350 enrolled MEDRx USA, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.

Timeline

Start
2010-07
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject MRX-7EAT Unknown — Topical

Indications

bursitis tendinitis